Atlas FDA

Reactiv8 Implantable Neurostimulation System

FDA premarket approval P190021/S004 · decided 2023-02-16

Approval details

PMA number
P190021
Supplement
S004
Supplement type
30-Day Notice
Supplement reason
Process Change - Manufacturer/Sterilizer/Packager/Supplier
Trade name
Reactiv8 Implantable Neurostimulation System
Generic name
Stimulator, neuromuscular, lower back muscles, totally implanted for pain relief
Applicant
Mainstay Medical Limited
Date received
2023-01-19
Decision date
2023-02-16
Days to decision
28 days
Decision code
OK30
Product code
QLK
Advisory committee
Neurology
Expedited review
No
Location
Swords, Co Dublin
Statement
Qualification of a commercially-available, equivalent programmer laptop for the ReActiv8 Implantable Neurostimulation System.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.